Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$9.81 - $15.4 $102,465 - $160,853
-10,445 Closed
0 $0
Q4 2021

Jan 25, 2022

SELL
$12.09 - $14.68 $16,019 - $19,451
-1,325 Reduced 11.26%
10,445 $141,000
Q3 2021

Oct 13, 2021

SELL
$13.25 - $15.13 $7,049 - $8,049
-532 Reduced 4.32%
11,770 $159,000
Q2 2021

Jul 13, 2021

SELL
$12.97 - $16.15 $23,955 - $29,829
-1,847 Reduced 13.05%
12,302 $176,000
Q1 2021

Apr 13, 2021

SELL
$13.59 - $18.54 $131,823 - $179,838
-9,700 Reduced 40.67%
14,149 $198,000
Q4 2020

Jan 15, 2021

BUY
$14.3 - $18.74 $341,040 - $446,930
23,849 New
23,849 $447,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.